Tuesday, November 5, 2024
HomeTagsALS therapeutics

ALS therapeutics

FDA Accelerated Approval of Tofersen Highlights Importance of Blood Neurofilament Light Chain as Surrogate Endpoint in Neurology Therapeutic Trials

Quanterix Corporation, a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, announced that blood-based NfL measurements provided compelling support for the...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics